Brii Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Brii Biosciences has a total shareholder equity of CN¥3.1B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥3.2B and CN¥125.9M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | n/a |
Cash | CN¥2.66b |
Equity | CN¥3.07b |
Total liabilities | CN¥125.87m |
Total assets | CN¥3.20b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7SS's short term assets (CN¥2.8B) exceed its short term liabilities (CN¥125.9M).
Long Term Liabilities: 7SS has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 7SS is debt free.
Reducing Debt: 7SS had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 7SS has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 7SS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.